Sans titre Dec5_16:53

For the treatment and prevention of bacterial and viral infections

Illustration: A child building sandcastles (design element)

Antimicrobial preparation for the treatment and prevention of infectious diseases

INSTRUCTIONS FOR USE

Therapeutic Agent

PHAGOVITA E

Dosage Form:

Lozenge (pastille)

Pharmacotherapeutic Group:

Antiseptic and immunobiological preparation for the treatment and prevention of infectious diseases of the oral cavity and throat.

Composition:

Active Components:

Bacteriophages active against:

• Streptococcus spp.
• Staphylococcus spp.
• Enterococcus spp.
• E. coli bacteriophages

Auxiliary substances:

• Sugar,
• Glucose,
• Citric acid,
• Flavors.

Pharmacological Action:

The preparation contains bacteriophages active against Streptococcus spp., Staphylococcus spp., Enterococcus spp., E. coli.

It suppresses the growth of pathogenic and conditionally pathogenic microorganisms in the oral cavity, throat, and upper respiratory mucosa.

The product helps regulate the microflora and reduces inflammation caused by bacterial infections.

Phagovita E is effective in diseases caused by the following bacteria:

• Streptococcus spp.
• Staphylococcus spp.
• Enterococcus spp.
• E. coli

It has an antibacterial effect and reduces the intensity of symptoms.

The preparation is sugar-based (80% sucrose or glucose), contains citric acid, and aromatic additives.

Indications:

Used preventively and therapeutically in conditions caused by bacterial infections of the oral cavity and throat:

• Sore throat
• Tonsillitis
• Laryngitis
• Pharyngitis
• Gingivitis
• Other inflammatory conditions of infectious origin

Contraindications:

Hypersensitivity to any component of the preparation.

Side Effects:

None observed.

Storage Conditions:

Store in a dry and cool place, protected from direct sunlight.